Biosafety Directive for Mycobacterium tuberculosis Complex (MTBC)

This biosafety directive is intended to provide a comprehensive overview of the risk assessment outcomes, subsequent containment level decisions, and considerations that have been made for those working with MTBC. It describes the activities and MTBC sample types that can be handled at CL2 with additional physical containment and operational practices. The Biosafety Directive for MTBC is to be used in conjunction with the CBS.

Data and Resources

Additional Info

Field	Value
Last Updated	April 17, 2026, 19:40 (UTC)
Created	April 17, 2026, 19:40 (UTC)
criticality_level	[]
geographic_scope	[]
open_canada_collection	publication
open_canada_date_published	2017-03-10 00:00:00
open_canada_keywords	{"fr": ["PATHOGÈNES ET GROUPES DE RISQUE", "COMPLEXE MYCOBACTERIUM TUBERCULOSIS", "GROUPE DE RISQUE", "NIVEAU DE CONFINEMENT", "BIOSÉCURITÉ", "ACTIVITÉS CLINIQUES OU DIAGNOSTIQUES AUTRES QUE LA CULTURE", "SOUCHES DE TB MR OU UR AUX ANTITUBERCULEUX", "TRANSFERT D'ÉCHANTILLONS", "DÉSINFECTION", "MÉTHODES D'INACTIVATION"], "en": ["PATHOGEN", "MYCOBACTERIUM TUBERCULOSIS COMPLEX", "CONTAINMENT LEVEL REQUIREMENTS", "BIOSAFETY REQUIREMENTS", "PRIMARY SPECIMENS", "CLINICAL/DIAGNOSTIC", "MDR-TB POSITIVE SPECIMENS", "XDR-TB POSITIVE SPECIMENS", "BIOSAFETY CONSIDERATIONS", "SPECIMEN REFERRAL", "PROPAGATIVE ACTIVITIES", "IN VIVO ACTIVITIES", "DISINFECTION", "INACTIVATION METHODS"]}
open_canada_subject	["health_and_safety"]
sensitivity_level	unrestricted
title_fr	Directive en matière de biosécurité portant sur le complexe Mycobacterium tuberculosis (CMTB)
update_frequency	unknown